肺炎治療薬の世界市場 2020年

• 英文タイトル：Global Pneumonia Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201114875 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、肺炎治療薬の世界市場を調査対象にし、肺炎治療薬の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（ワクチン、抗感染薬、酸素療法）、用途別分析（病院、診療所、医療センター、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：GlaxoSmithKline、Tetraphase Pharmaceuticals、Pfizer、Merck Sharp & Dohme、Biotest、Novartis、Bayer、AstraZeneca ・企業別売上、市場シェア ・肺炎治療薬の地域別市場分析 ・肺炎治療薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・肺炎治療薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・肺炎治療薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・肺炎治療薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・肺炎治療薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・肺炎治療薬の種類別市場規模2015-2020：ワクチン、抗感染薬、酸素療法 ・肺炎治療薬の用途別市場規模2015-2020：病院、診療所、医療センター、その他 ・肺炎治療薬の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Pneumonia Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.4% in the forecast period of 2020 to 2025 and will expected to reach USD 15840 million by 2025, from USD 12350 million in 2019.

The Pneumonia Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Pneumonia Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Pneumonia Therapeutics market has been segmented into:
Vaccines
Anti-Infectives
Oxygen Therapy

By Application, Pneumonia Therapeutics has been segmented into:
Hospital
Clinic
Medical Center
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pneumonia Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Pneumonia Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pneumonia Therapeutics market.

The report offers in-depth assessment of the growth and other aspects of the Pneumonia Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Pneumonia Therapeutics Market Share Analysis
Pneumonia Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pneumonia Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pneumonia Therapeutics sales, revenue and market share for each player covered in this report.

The major players covered in Pneumonia Therapeutics are:
GlaxoSmithKline
Tetraphase Pharmaceuticals
Pfizer
Merck Sharp & Dohme
Biotest
Novartis
Bayer
AstraZeneca

レポート目次

---

Table of Contents

1 Pneumonia Therapeutics Market Overview
1.1 Product Overview and Scope of Pneumonia Therapeutics
1.2 Classification of Pneumonia Therapeutics by Type
1.2.1 Global Pneumonia Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Pneumonia Therapeutics Revenue Market Share by Type in 2019
1.2.3 Vaccines
1.2.4 Anti-Infectives
1.2.5 Oxygen Therapy
1.3 Global Pneumonia Therapeutics Market by Application
1.3.1 Overview: Global Pneumonia Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Medical Center
1.3.5 Other
1.4 Global Pneumonia Therapeutics Market by Regions
1.4.1 Global Pneumonia Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Pneumonia Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Pneumonia Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Pneumonia Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pneumonia Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Pneumonia Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pneumonia Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GlaxoSmithKline SWOT Analysis
2.1.4 GlaxoSmithKline Product and Services
2.1.5 GlaxoSmithKline Pneumonia Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Tetraphase Pharmaceuticals
2.2.1 Tetraphase Pharmaceuticals Details
2.2.2 Tetraphase Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Tetraphase Pharmaceuticals SWOT Analysis
2.2.4 Tetraphase Pharmaceuticals Product and Services
2.2.5 Tetraphase Pharmaceuticals Pneumonia Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer SWOT Analysis
2.3.4 Pfizer Product and Services
2.3.5 Pfizer Pneumonia Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck Sharp & Dohme
2.4.1 Merck Sharp & Dohme Details
2.4.2 Merck Sharp & Dohme Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck Sharp & Dohme SWOT Analysis
2.4.4 Merck Sharp & Dohme Product and Services
2.4.5 Merck Sharp & Dohme Pneumonia Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Biotest
2.5.1 Biotest Details
2.5.2 Biotest Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Biotest SWOT Analysis
2.5.4 Biotest Product and Services
2.5.5 Biotest Pneumonia Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis SWOT Analysis
2.6.4 Novartis Product and Services
2.6.5 Novartis Pneumonia Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bayer
2.7.1 Bayer Details
2.7.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bayer SWOT Analysis
2.7.4 Bayer Product and Services
2.7.5 Bayer Pneumonia Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AstraZeneca SWOT Analysis
2.8.4 AstraZeneca Product and Services
2.8.5 AstraZeneca Pneumonia Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Pneumonia Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Pneumonia Therapeutics Players Market Share
3.2.2 Top 10 Pneumonia Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Pneumonia Therapeutics Revenue and Market Share by Regions
4.2 North America Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Pneumonia Therapeutics Revenue by Countries
5.1 North America Pneumonia Therapeutics Revenue by Countries (2015-2020)
5.2 USA Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Pneumonia Therapeutics Revenue by Countries
6.1 Europe Pneumonia Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Pneumonia Therapeutics Revenue by Countries
7.1 Asia-Pacific Pneumonia Therapeutics Revenue by Countries (2015-2020)
7.2 China Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Pneumonia Therapeutics Revenue by Countries
8.1 South America Pneumonia Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Pneumonia Therapeutics by Countries
9.1 Middle East & Africa Pneumonia Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Pneumonia Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Pneumonia Therapeutics Market Forecast by Type (2019-2024)
10.3 Vaccines Revenue Growth Rate (2015-2025)
10.4 Anti-Infectives Revenue Growth Rate (2015-2025)
10.5 Oxygen Therapy Revenue Growth Rate (2015-2025)
11 Global Pneumonia Therapeutics Market Segment by Application
11.1 Global Pneumonia Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Pneumonia Therapeutics Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Medical Center Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global Pneumonia Therapeutics Market Size Forecast (2021-2025)
12.1 Global Pneumonia Therapeutics Market Size Forecast (2021-2025)
12.2 Global Pneumonia Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Pneumonia Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Pneumonia Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Pneumonia Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Pneumonia Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Pneumonia Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Pneumonia Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Pneumonia Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Pneumonia Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Pneumonia Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. GlaxoSmithKline Corporate Information, Location and Competitors
Table 6. GlaxoSmithKline Pneumonia Therapeutics Major Business
Table 7. GlaxoSmithKline Pneumonia Therapeutics Total Revenue (USD Million) (2017-2018)
Table 8. GlaxoSmithKline SWOT Analysis
Table 9. GlaxoSmithKline Pneumonia Therapeutics Product and Solutions
Table 10. GlaxoSmithKline Pneumonia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Tetraphase Pharmaceuticals Corporate Information, Location and Competitors
Table 12. Tetraphase Pharmaceuticals Pneumonia Therapeutics Major Business
Table 13. Tetraphase Pharmaceuticals Pneumonia Therapeutics Total Revenue (USD Million) (2018-2019)
Table 14. Tetraphase Pharmaceuticals SWOT Analysis
Table 15. Tetraphase Pharmaceuticals Pneumonia Therapeutics Product and Solutions
Table 16. Tetraphase Pharmaceuticals Pneumonia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Pfizer Corporate Information, Location and Competitors
Table 18. Pfizer Pneumonia Therapeutics Major Business
Table 19. Pfizer Pneumonia Therapeutics Total Revenue (USD Million) (2017-2018)
Table 20. Pfizer SWOT Analysis
Table 21. Pfizer Pneumonia Therapeutics Product and Solutions
Table 22. Pfizer Pneumonia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Merck Sharp & Dohme Corporate Information, Location and Competitors
Table 24. Merck Sharp & Dohme Pneumonia Therapeutics Major Business
Table 25. Merck Sharp & Dohme Pneumonia Therapeutics Total Revenue (USD Million) (2017-2018)
Table 26. Merck Sharp & Dohme SWOT Analysis
Table 27. Merck Sharp & Dohme Pneumonia Therapeutics Product and Solutions
Table 28. Merck Sharp & Dohme Pneumonia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Biotest Corporate Information, Location and Competitors
Table 30. Biotest Pneumonia Therapeutics Major Business
Table 31. Biotest Pneumonia Therapeutics Total Revenue (USD Million) (2017-2018)
Table 32. Biotest SWOT Analysis
Table 33. Biotest Pneumonia Therapeutics Product and Solutions
Table 34. Biotest Pneumonia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Novartis Corporate Information, Location and Competitors
Table 36. Novartis Pneumonia Therapeutics Major Business
Table 37. Novartis Pneumonia Therapeutics Total Revenue (USD Million) (2017-2018)
Table 38. Novartis SWOT Analysis
Table 39. Novartis Pneumonia Therapeutics Product and Solutions
Table 40. Novartis Pneumonia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Bayer Corporate Information, Location and Competitors
Table 42. Bayer Pneumonia Therapeutics Major Business
Table 43. Bayer Pneumonia Therapeutics Total Revenue (USD Million) (2017-2018)
Table 44. Bayer SWOT Analysis
Table 45. Bayer Pneumonia Therapeutics Product and Solutions
Table 46. Bayer Pneumonia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. AstraZeneca Corporate Information, Location and Competitors
Table 48. AstraZeneca Pneumonia Therapeutics Major Business
Table 49. AstraZeneca Pneumonia Therapeutics Total Revenue (USD Million) (2017-2018)
Table 50. AstraZeneca SWOT Analysis
Table 51. AstraZeneca Pneumonia Therapeutics Product and Solutions
Table 52. AstraZeneca Pneumonia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Pneumonia Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 54. Global Pneumonia Therapeutics Revenue Share by Players (2015-2020)
Table 55. Global Pneumonia Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Pneumonia Therapeutics Revenue Market Share by Regions (2015-2020)
Table 57. North America Pneumonia Therapeutics Revenue by Countries (2015-2020)
Table 58. North America Pneumonia Therapeutics Revenue Market Share by Countries (2015-2020)
Table 59. Europe Pneumonia Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Pneumonia Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Pneumonia Therapeutics Revenue by Countries (2015-2020)
Table 62. South America Pneumonia Therapeutics Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Pneumonia Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Pneumonia Therapeutics Revenue Market Share by Countries (2015-2020)
Table 65. Global Pneumonia Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 66. Global Pneumonia Therapeutics Revenue Share by Type (2015-2020)
Table 67. Global Pneumonia Therapeutics Revenue Forecast by Type (2021-2025)
Table 68. Global Pneumonia Therapeutics Revenue by Application (2015-2020)
Table 69. Global Pneumonia Therapeutics Revenue Share by Application (2015-2020)
Table 70. Global Pneumonia Therapeutics Revenue Forecast by Application (2021-2025)
Table 71. Global Pneumonia Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Pneumonia Therapeutics Picture
Figure 2. Global Pneumonia Therapeutics Revenue Market Share by Type in 2019
Figure 3. Vaccines Picture
Figure 4. Anti-Infectives Picture
Figure 5. Oxygen Therapy Picture
Figure 6. Pneumonia Therapeutics Revenue Market Share by Application in 2019
Figure 7. Hospital Picture
Figure 8. Clinic Picture
Figure 9. Medical Center Picture
Figure 10. Other Picture
Figure 11. Global Pneumonia Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Pneumonia Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Pneumonia Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Pneumonia Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Pneumonia Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Pneumonia Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Pneumonia Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Pneumonia Therapeutics Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Pneumonia Therapeutics Revenue Market Share in 2019
Figure 20. Global Top 10 Players Pneumonia Therapeutics Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Pneumonia Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Pneumonia Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 24. Global Pneumonia Therapeutics Revenue Market Share by Regions in 2018
Figure 25. North America Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 26. Europe Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 28. South America Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 30. North America Pneumonia Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 31. North America Pneumonia Therapeutics Revenue Market Share by Countries in 2019
Figure 32. USA Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 33. Canada Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 35. Europe Pneumonia Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Pneumonia Therapeutics Revenue Market Share by Countries in 2019
Figure 37. Germany Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 38. UK Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 39. France Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 40. Russia Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 41. Italy Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Pneumonia Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Pneumonia Therapeutics Revenue Market Share by Countries in 2019
Figure 44. China Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 45. Japan Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 46. Korea Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 47. India Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 49. South America Pneumonia Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 50. South America Pneumonia Therapeutics Revenue Market Share by Countries in 2019
Figure 51. Brazil Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Pneumonia Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Pneumonia Therapeutics Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 56. UAE Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Pneumonia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 59. Global Pneumonia Therapeutics Revenue Share by Type (2015-2020)
Figure 60. Global Pneumonia Therapeutics Revenue Share by Type in 2019
Figure 61. Global Pneumonia Therapeutics Market Share Forecast by Type (2021-2025)
Figure 62. Global Vaccines Revenue Growth Rate (2015-2020)
Figure 63. Global Anti-Infectives Revenue Growth Rate (2015-2020)
Figure 64. Global Oxygen Therapy Revenue Growth Rate (2015-2020)
Figure 65. Global Pneumonia Therapeutics Revenue Share by Application (2015-2020)
Figure 66. Global Pneumonia Therapeutics Revenue Share by Application in 2019
Figure 67. Global Pneumonia Therapeutics Market Share Forecast by Application (2021-2025)
Figure 68. Global Hospital Revenue Growth Rate (2015-2020)
Figure 69. Global Clinic Revenue Growth Rate (2015-2020)
Figure 70. Global Medical Center Revenue Growth Rate (2015-2020)
Figure 71. Global Other Revenue Growth Rate (2015-2020)
Figure 72. Global Pneumonia Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Pneumonia Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Pneumonia Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Pneumonia Therapeutics Revenue Market Forecast (2021-2025)
Figure 76. Europe Pneumonia Therapeutics Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Pneumonia Therapeutics Revenue Market Forecast (2021-2025)
Figure 78. South America Pneumonia Therapeutics Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Pneumonia Therapeutics Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---